Expression of GADD153 in tumor cells and stromal cells from xenografted tumors in nude mice treated with cisplatin: correlations with cisplatin-DNA adducts.
Cisplatin is a commonly used antineoplastic agent that acts by forming adducts with DNA, and causing a response to the cellular injury. One of the components of this cellular injury response is the activation of the "growth arrest and DNA damage gene" GADD153. The level of GADD153 induction in tumor cells has been associated with the degree of cytotoxicity. The pupose of this study was to determine whether cisplatin activates GADD153 also in nontumor cells and how GADD153 protein levels correlate with cisplatin-DNA adducts in different cell types. Nude mice with xenografted squamous cell carcinoma were treated with cisplatin 10 mg/kg. Tumors were removed at 0 h (untreated controls), 24 h, and 48 h and immunohistochemically stained for GADD153 protein and cisplatin-DNA adducts. The staining reaction was quantitated in tumor cells and nonmalignant stromal cells separately, using computerized image analysis. The GADD153 level was 4.5 times higher in tumor cells than in stromal cells in untreated mice. At 24 h after cisplatin treatment the GADD153 level had increased by 50% and 72% in tumor cells and stromal cells, respectively. Analysis of the cisplatin-DNA adducts showed a reversed pattern, with six-fold higher levels in stromal cells than in tumor cells at 24 h after treatment. By combining these data, we estimated that approximately 25-fold more GADD153 per cisplatin-DNA adduct was induced in tumor cells than in stromal cells. Our data suggest that different cell types may respond differently to DNA damage caused by cisplatin.